NCFBE突破性药物！brensocatib II期临床：显著降低肺加重风险
科普小医森
发布时间：2020-06-30 19:09
205次浏览
关键词：
原文出处：Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at ATS Virtual Clinical Trials Session
